Acuta Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History

Acuta Capital Partners’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$5.49M	Buy
2019 Q2	$3.72M	Buy
2018 Q2	–	Hold
2018 Q1	–	Hold
2017 Q4	–	Hold